APOB and atherosclerosis: Immunization of LDLr−/− (LDLrtm1Her) mice expressing human ApoB100 with P210 (human ApoB1003136-3155) has shown to reduce atherosclerosis in pre-clinical studies and the mechanism of action of this therapeutic strategy has been related to the induction of Tregs.